Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dietary Supplements | 45 | 2024 | 3443 | 8.400 |
Why?
|
United States Food and Drug Administration | 19 | 2024 | 1672 | 3.430 |
Why?
|
Drug Contamination | 10 | 2024 | 151 | 3.280 |
Why?
|
Consumer Product Safety | 7 | 2021 | 122 | 2.680 |
Why?
|
Legislation, Food | 4 | 2022 | 17 | 2.350 |
Why?
|
Anti-Obesity Agents | 7 | 2021 | 240 | 2.250 |
Why?
|
Amphetamines | 7 | 2021 | 143 | 2.150 |
Why?
|
Legislation, Drug | 4 | 2019 | 216 | 1.500 |
Why?
|
Drug Labeling | 3 | 2024 | 250 | 1.480 |
Why?
|
Central Nervous System Stimulants | 6 | 2021 | 1181 | 1.390 |
Why?
|
Drug Recalls | 3 | 2022 | 20 | 1.390 |
Why?
|
Cannabidiol | 2 | 2023 | 123 | 1.300 |
Why?
|
Amines | 4 | 2021 | 280 | 1.210 |
Why?
|
Government Regulation | 6 | 2024 | 525 | 1.190 |
Why?
|
Drug Approval | 4 | 2019 | 818 | 1.030 |
Why?
|
Vinca Alkaloids | 2 | 2015 | 36 | 1.020 |
Why?
|
Piracetam | 2 | 2020 | 88 | 1.020 |
Why?
|
Chromatography, High Pressure Liquid | 8 | 2018 | 1539 | 1.010 |
Why?
|
Appetite Depressants | 4 | 2012 | 108 | 1.000 |
Why?
|
Probiotics | 2 | 2019 | 383 | 0.950 |
Why?
|
Foodborne Diseases | 1 | 2024 | 41 | 0.930 |
Why?
|
Galantamine | 1 | 2024 | 33 | 0.900 |
Why?
|
Maleic Anhydrides | 2 | 2013 | 8 | 0.850 |
Why?
|
Meclofenoxate | 1 | 2022 | 1 | 0.840 |
Why?
|
Mucuna | 1 | 2022 | 6 | 0.840 |
Why?
|
Safety-Based Drug Withdrawals | 2 | 2013 | 36 | 0.830 |
Why?
|
Methanol | 1 | 2022 | 91 | 0.790 |
Why?
|
Tetrahydroisoquinolines | 2 | 2021 | 81 | 0.780 |
Why?
|
Ephedrine | 3 | 2021 | 52 | 0.750 |
Why?
|
Doping in Sports | 2 | 2018 | 62 | 0.750 |
Why?
|
Nootropic Agents | 2 | 2020 | 159 | 0.750 |
Why?
|
Adrenergic Agonists | 1 | 2021 | 57 | 0.740 |
Why?
|
Alkaloids | 2 | 2021 | 192 | 0.730 |
Why?
|
Sports | 3 | 2023 | 703 | 0.710 |
Why?
|
Housekeeping, Hospital | 1 | 2020 | 17 | 0.700 |
Why?
|
Health Facility Environment | 1 | 2020 | 32 | 0.690 |
Why?
|
Testosterone Congeners | 1 | 2020 | 62 | 0.670 |
Why?
|
Food Safety | 2 | 2024 | 23 | 0.630 |
Why?
|
Drugs, Generic | 1 | 2024 | 454 | 0.630 |
Why?
|
Product Labeling | 2 | 2015 | 76 | 0.600 |
Why?
|
United States | 33 | 2024 | 73150 | 0.600 |
Why?
|
Disinfection | 1 | 2020 | 207 | 0.600 |
Why?
|
Melatonin | 1 | 2023 | 669 | 0.580 |
Why?
|
Jurisprudence | 1 | 2018 | 109 | 0.580 |
Why?
|
Cannabis | 1 | 2023 | 445 | 0.550 |
Why?
|
Drug Industry | 3 | 2019 | 793 | 0.540 |
Why?
|
Biological Phenomena | 1 | 2016 | 28 | 0.540 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2021 | 628 | 0.540 |
Why?
|
Total Quality Management | 1 | 2018 | 265 | 0.540 |
Why?
|
Medical History Taking | 1 | 2020 | 776 | 0.530 |
Why?
|
Expert Testimony | 1 | 2018 | 266 | 0.520 |
Why?
|
Yohimbine | 1 | 2015 | 62 | 0.510 |
Why?
|
Acacia | 1 | 2015 | 2 | 0.500 |
Why?
|
Quality Control | 2 | 2018 | 833 | 0.500 |
Why?
|
Methamphetamine | 2 | 2014 | 167 | 0.480 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2016 | 267 | 0.480 |
Why?
|
Mass Spectrometry | 6 | 2018 | 2201 | 0.460 |
Why?
|
Pharmaceutical Preparations | 2 | 2022 | 1088 | 0.460 |
Why?
|
Laboratories | 1 | 2018 | 463 | 0.450 |
Why?
|
Phytotherapy | 1 | 2016 | 298 | 0.440 |
Why?
|
gamma-Aminobutyric Acid | 2 | 2021 | 1143 | 0.440 |
Why?
|
Military Facilities | 1 | 2013 | 4 | 0.440 |
Why?
|
Plant Preparations | 2 | 2012 | 94 | 0.430 |
Why?
|
Cardiotonic Agents | 1 | 2016 | 544 | 0.420 |
Why?
|
Micronutrients | 1 | 2016 | 390 | 0.410 |
Why?
|
Infection Control | 1 | 2020 | 985 | 0.410 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2013 | 103 | 0.410 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3118 | 0.400 |
Why?
|
Hyperlipidemias | 1 | 2017 | 773 | 0.400 |
Why?
|
Respiratory Tract Infections | 1 | 2020 | 1014 | 0.400 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3241 | 0.400 |
Why?
|
Pneumococcal Vaccines | 1 | 2015 | 414 | 0.390 |
Why?
|
Plant Extracts | 1 | 2015 | 499 | 0.390 |
Why?
|
Phentermine | 1 | 2011 | 31 | 0.380 |
Why?
|
Heart Rate | 2 | 2013 | 4218 | 0.360 |
Why?
|
Pneumococcal Infections | 1 | 2015 | 529 | 0.360 |
Why?
|
Cross Infection | 1 | 2020 | 1426 | 0.360 |
Why?
|
Sulfones | 1 | 2013 | 448 | 0.360 |
Why?
|
Chlordiazepoxide | 1 | 2010 | 42 | 0.360 |
Why?
|
Alcoholism | 1 | 2021 | 1982 | 0.360 |
Why?
|
Biological Products | 2 | 2017 | 934 | 0.360 |
Why?
|
Pandemics | 3 | 2021 | 8753 | 0.350 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2014 | 495 | 0.350 |
Why?
|
Heptanes | 2 | 2021 | 8 | 0.340 |
Why?
|
Marketing | 1 | 2012 | 224 | 0.330 |
Why?
|
Self Medication | 1 | 2010 | 115 | 0.330 |
Why?
|
Caffeine | 2 | 2016 | 702 | 0.330 |
Why?
|
Intracranial Hemorrhages | 1 | 2015 | 811 | 0.330 |
Why?
|
Fructose | 1 | 2011 | 284 | 0.330 |
Why?
|
Ambulatory Care | 1 | 2020 | 2784 | 0.320 |
Why?
|
Reference Standards | 4 | 2015 | 1013 | 0.310 |
Why?
|
Humans | 53 | 2024 | 768393 | 0.290 |
Why?
|
Brazil | 5 | 2012 | 1248 | 0.280 |
Why?
|
Blood Pressure | 2 | 2013 | 8541 | 0.280 |
Why?
|
Limit of Detection | 3 | 2016 | 276 | 0.270 |
Why?
|
Fluoxetine | 1 | 2010 | 735 | 0.260 |
Why?
|
Substance Abuse Detection | 1 | 2009 | 300 | 0.260 |
Why?
|
Organizations, Nonprofit | 1 | 2006 | 105 | 0.260 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3236 | 0.250 |
Why?
|
Cloning, Organism | 1 | 2005 | 50 | 0.250 |
Why?
|
Nuclear Transfer Techniques | 1 | 2005 | 61 | 0.250 |
Why?
|
Social Control, Formal | 1 | 2005 | 107 | 0.240 |
Why?
|
Emigrants and Immigrants | 1 | 2011 | 549 | 0.240 |
Why?
|
Primary Prevention | 1 | 2012 | 1187 | 0.230 |
Why?
|
House Calls | 1 | 2006 | 171 | 0.230 |
Why?
|
Cardiovascular Agents | 1 | 2010 | 849 | 0.220 |
Why?
|
Octopamine | 2 | 2021 | 43 | 0.220 |
Why?
|
Weight Loss | 2 | 2012 | 2713 | 0.220 |
Why?
|
Dosage Forms | 1 | 2023 | 56 | 0.220 |
Why?
|
Calcinosis | 1 | 2012 | 1481 | 0.210 |
Why?
|
Vaccination | 1 | 2015 | 3431 | 0.210 |
Why?
|
Product Recalls and Withdrawals | 1 | 2022 | 7 | 0.210 |
Why?
|
Substance-Related Disorders | 2 | 2010 | 4429 | 0.210 |
Why?
|
Piperazines | 1 | 2013 | 2552 | 0.200 |
Why?
|
Powders | 1 | 2022 | 79 | 0.200 |
Why?
|
Models, Educational | 2 | 2012 | 375 | 0.200 |
Why?
|
Levodopa | 1 | 2022 | 223 | 0.190 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 8051 | 0.190 |
Why?
|
Chromatography, Liquid | 2 | 2015 | 997 | 0.180 |
Why?
|
Anticonvulsants | 1 | 2011 | 1923 | 0.180 |
Why?
|
Physician's Role | 1 | 2007 | 926 | 0.180 |
Why?
|
Suicidal Ideation | 1 | 2011 | 1462 | 0.180 |
Why?
|
Prescription Drugs | 1 | 2007 | 634 | 0.180 |
Why?
|
Synephrine | 2 | 2016 | 2 | 0.170 |
Why?
|
Poetry as Topic | 1 | 1999 | 17 | 0.160 |
Why?
|
History, 20th Century | 3 | 2012 | 2771 | 0.160 |
Why?
|
Attitude to Health | 1 | 2007 | 2025 | 0.160 |
Why?
|
Clinical Clerkship | 2 | 2012 | 566 | 0.150 |
Why?
|
Exercise | 1 | 2015 | 5946 | 0.150 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2012 | 4047 | 0.150 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7453 | 0.150 |
Why?
|
Students, Medical | 2 | 2012 | 1964 | 0.150 |
Why?
|
Communication | 4 | 2022 | 3912 | 0.150 |
Why?
|
Gas Chromatography-Mass Spectrometry | 2 | 2015 | 352 | 0.140 |
Why?
|
Massachusetts | 5 | 2021 | 8902 | 0.140 |
Why?
|
Physiological Phenomena | 1 | 2016 | 18 | 0.140 |
Why?
|
Learning | 1 | 2006 | 1761 | 0.140 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2020 | 794 | 0.130 |
Why?
|
Pausinystalia | 1 | 2015 | 1 | 0.130 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 7955 | 0.130 |
Why?
|
Camellia sinensis | 1 | 2015 | 8 | 0.130 |
Why?
|
Epilepsy | 1 | 2011 | 3326 | 0.120 |
Why?
|
Citrinin | 1 | 2014 | 1 | 0.120 |
Why?
|
Administration, Oral | 1 | 2023 | 4039 | 0.120 |
Why?
|
Chromatography, Reverse-Phase | 1 | 2014 | 24 | 0.120 |
Why?
|
Cyclobutanes | 2 | 2012 | 57 | 0.120 |
Why?
|
Plant Leaves | 1 | 2015 | 153 | 0.120 |
Why?
|
Drug Combinations | 2 | 2011 | 2079 | 0.120 |
Why?
|
Lovastatin | 1 | 2014 | 115 | 0.110 |
Why?
|
Food Labeling | 1 | 2016 | 181 | 0.110 |
Why?
|
Food Inspection | 1 | 2012 | 3 | 0.100 |
Why?
|
Internship and Residency | 2 | 2006 | 5949 | 0.100 |
Why?
|
Obesity | 3 | 2011 | 13084 | 0.100 |
Why?
|
Risk | 1 | 2024 | 9636 | 0.100 |
Why?
|
Coronary Artery Disease | 1 | 2012 | 6567 | 0.100 |
Why?
|
Liver Failure, Acute | 1 | 2014 | 182 | 0.100 |
Why?
|
Phenolphthalein | 1 | 2011 | 5 | 0.100 |
Why?
|
Morbidity | 1 | 2017 | 1758 | 0.100 |
Why?
|
Risk Assessment | 3 | 2021 | 24318 | 0.100 |
Why?
|
Food Contamination | 1 | 2012 | 193 | 0.090 |
Why?
|
Spain | 1 | 2012 | 492 | 0.090 |
Why?
|
Herb-Drug Interactions | 1 | 2010 | 8 | 0.090 |
Why?
|
Neoplasms | 1 | 2020 | 22385 | 0.090 |
Why?
|
Drug Evaluation | 1 | 2012 | 642 | 0.090 |
Why?
|
History, 19th Century | 1 | 2012 | 715 | 0.080 |
Why?
|
Purines | 1 | 2013 | 615 | 0.080 |
Why?
|
Erectile Dysfunction | 1 | 2013 | 445 | 0.080 |
Why?
|
Schools, Medical | 2 | 2012 | 881 | 0.080 |
Why?
|
Panic Disorder | 1 | 2012 | 613 | 0.080 |
Why?
|
Tandem Mass Spectrometry | 1 | 2014 | 1197 | 0.070 |
Why?
|
Drug and Narcotic Control | 1 | 2009 | 145 | 0.070 |
Why?
|
Education, Medical, Undergraduate | 2 | 2012 | 1082 | 0.070 |
Why?
|
Tachycardia | 1 | 2009 | 598 | 0.070 |
Why?
|
Assisted Living Facilities | 1 | 2006 | 27 | 0.070 |
Why?
|
History, 21st Century | 1 | 2012 | 1575 | 0.070 |
Why?
|
Antihypertensive Agents | 1 | 2015 | 2027 | 0.060 |
Why?
|
Clothing | 1 | 2006 | 96 | 0.060 |
Why?
|
Curriculum | 1 | 1999 | 3776 | 0.060 |
Why?
|
China | 1 | 2011 | 2395 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 1999 | 3922 | 0.060 |
Why?
|
Educational Measurement | 1 | 2012 | 1256 | 0.060 |
Why?
|
Cognition | 1 | 2022 | 7075 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 13020 | 0.060 |
Why?
|
Culture Techniques | 1 | 2005 | 530 | 0.060 |
Why?
|
Benzodiazepines | 1 | 2010 | 1139 | 0.060 |
Why?
|
Female | 9 | 2016 | 397089 | 0.050 |
Why?
|
Sexual Behavior | 1 | 2013 | 2200 | 0.050 |
Why?
|
Health Education | 1 | 2010 | 1057 | 0.050 |
Why?
|
Disease Progression | 1 | 2020 | 13646 | 0.050 |
Why?
|
Primary Health Care | 1 | 1999 | 4748 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 3252 | 0.050 |
Why?
|
Liver Transplantation | 1 | 2014 | 2400 | 0.050 |
Why?
|
Chest Pain | 1 | 2009 | 1099 | 0.050 |
Why?
|
Embryo Transfer | 1 | 2005 | 527 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10844 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 2012 | 2056 | 0.040 |
Why?
|
Interpersonal Relations | 1 | 2007 | 1440 | 0.040 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2009 | 1099 | 0.040 |
Why?
|
Seizures | 1 | 2012 | 3000 | 0.040 |
Why?
|
Teaching | 1 | 2006 | 1172 | 0.040 |
Why?
|
Adult | 5 | 2011 | 223640 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3707 | 0.040 |
Why?
|
Women's Health | 1 | 2007 | 2078 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2007 | 2337 | 0.040 |
Why?
|
Fertilization in Vitro | 1 | 2005 | 1302 | 0.030 |
Why?
|
Pseudoephedrine | 1 | 2016 | 3 | 0.030 |
Why?
|
Physician-Patient Relations | 1 | 2010 | 3267 | 0.030 |
Why?
|
Strychnine | 1 | 2016 | 34 | 0.030 |
Why?
|
Phenylpropanolamine | 1 | 2016 | 15 | 0.030 |
Why?
|
Program Evaluation | 2 | 2012 | 2505 | 0.030 |
Why?
|
Comorbidity | 1 | 2011 | 10588 | 0.030 |
Why?
|
Chromatography, Thin Layer | 1 | 2015 | 212 | 0.030 |
Why?
|
Male | 5 | 2013 | 364902 | 0.030 |
Why?
|
Ambulatory Care Facilities | 1 | 2021 | 941 | 0.030 |
Why?
|
Discriminant Analysis | 1 | 2014 | 222 | 0.030 |
Why?
|
Azo Compounds | 1 | 2014 | 116 | 0.030 |
Why?
|
Middle Aged | 3 | 2015 | 223491 | 0.030 |
Why?
|
Young Adult | 2 | 2011 | 60049 | 0.030 |
Why?
|
Electrophoresis, Capillary | 1 | 2012 | 63 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36849 | 0.030 |
Why?
|
Aged | 3 | 2021 | 171562 | 0.020 |
Why?
|
Calibration | 1 | 2014 | 823 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20765 | 0.020 |
Why?
|
Laxatives | 1 | 2012 | 95 | 0.020 |
Why?
|
Electric Conductivity | 1 | 2012 | 408 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2014 | 948 | 0.020 |
Why?
|
Mental Disorders | 1 | 2011 | 6876 | 0.020 |
Why?
|
Program Development | 1 | 2007 | 1298 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 26375 | 0.020 |
Why?
|
Anti-Anxiety Agents | 1 | 2012 | 405 | 0.020 |
Why?
|
Animals | 2 | 2012 | 169337 | 0.020 |
Why?
|
Diuretics | 1 | 2012 | 612 | 0.020 |
Why?
|
Risk Factors | 2 | 2021 | 74962 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2015 | 20224 | 0.020 |
Why?
|
Linear Models | 1 | 2014 | 5878 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10776 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2010 | 65379 | 0.010 |
Why?
|
Pregnancy | 1 | 2005 | 30200 | 0.010 |
Why?
|
Child | 1 | 2011 | 80891 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8731 | 0.010 |
Why?
|
Adolescent | 1 | 2011 | 89184 | 0.010 |
Why?
|
Clinical Competence | 1 | 2007 | 4848 | 0.010 |
Why?
|
Antidepressive Agents | 1 | 2012 | 2913 | 0.010 |
Why?
|
Time Factors | 1 | 2016 | 40272 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2012 | 81801 | 0.000 |
Why?
|
Concepts
(245)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_